Clayton Dubilier & Rice’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,456
Closed -$56.8K 6
2023
Q2
$56.8K Hold
1,456
﹤0.01% 7
2023
Q1
$52.7K Hold
1,456
﹤0.01% 7
2022
Q4
$44.9K Buy
+1,456
New +$45.2K ﹤0.01% 7

Other funds holding RTO

Clayton Dubilier & Rice's RTO Position: Q3 2023 in Review

Clayton Dubilier & Rice sold out of Rentokil (RTO) in Q3 2023, closing a stake of 1,456 shares — an estimated $56.8K sold.

Clayton Dubilier & Rice first reported a position in RTO in Q4 2022 and held it in 3 quarters. The position peaked at $56.8K in Q2 2023. 194 funds tracked by Wall St. Rank hold RTO as of Q3 2023.

  • Clayton Dubilier & Rice reported no remaining Rentokil position as of Q3 2023 after selling out during the quarter.
  • Clayton Dubilier & Rice sold 1,456 Rentokil shares in Q3 2023, an estimated $56.8K.
  • Clayton Dubilier & Rice first reported a position in Rentokil in Q4 2022 and held it in 3 quarters.
  • Clayton Dubilier & Rice's Rentokil position peaked at $56.8K in Q2 2023.
  • 194 funds tracked by Wall St. Rank held Rentokil as of Q3 2023.

Based on Clayton Dubilier & Rice's 13F filing for Q3 2023, filed 3 Nov 2023.